Abstract
The role of low-density lipoprotein-cholesterol in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) is well established. Lipid management remains the cornerstone of addressing ASCVD. In addition to statin therapy, there is a large and growing number of nonstatin therapies available to manage elevated cholesterol levels. This expert panel seeks to review current international recommendations regarding lipid management. In addition, complex yet commonly encountered lipid-management cases are provided. Guidance on applying guideline-based recommendations as well as newer evidence to the evaluation and management of ASCVD-risk lipid management is then provided.
| Original language | English (US) |
|---|---|
| Article number | 101823 |
| Journal | JACC: Advances |
| Volume | 4 |
| Issue number | 6P2 |
| DOIs | |
| State | Published - Jun 2025 |
Keywords
- atherosclerotic cardiovascular disease
- cholesterol
- lipids
- pharmacotherapy
- prevention
- statins
- triglycerides
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine